Your browser doesn't support javascript.
loading
Metabolic syndrome is associated with improved cancer-specific survival in patients with localized clear cell renal cell carcinoma.
Liu, Zhenhua; Wang, Haifeng; Zhang, Lian; Li, Shaobo; Fan, Yu; Meng, Yisen; Hu, Shuai; Zhang, Qian; He, Zhisong; Zhou, Liqun; Han, Wenke; Yu, Wei; Jin, Jie.
Afiliación
  • Liu Z; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Wang H; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Zhang L; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Li S; School of Basic Medicine, Fudan University, Shanghai 200032, China.
  • Fan Y; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Meng Y; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Hu S; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Zhang Q; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • He Z; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Zhou L; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Han W; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Yu W; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
  • Jin J; Department of Urology, Peking University First Hospital and Institute of Urology, National Research Center for Genitourinary Oncology, Beijing 100034, China.
Transl Androl Urol ; 8(5): 507-518, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31807427
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Androl Urol Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Androl Urol Año: 2019 Tipo del documento: Article País de afiliación: China